182 related articles for article (PubMed ID: 2159632)
1. Distamycin inhibition of topoisomerase I-DNA interaction: a mechanistic analysis.
Mortensen UH; Stevnsner T; Krogh S; Olesen K; Westergaard O; Bonven BJ
Nucleic Acids Res; 1990 Apr; 18(8):1983-9. PubMed ID: 2159632
[TBL] [Abstract][Full Text] [Related]
2. Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
Fesen M; Pommier Y
J Biol Chem; 1989 Jul; 264(19):11354-9. PubMed ID: 2544590
[TBL] [Abstract][Full Text] [Related]
3. Effect of minor groove binding drugs on mammalian topoisomerase I activity.
McHugh MM; Woynarowski JM; Sigmund RD; Beerman TA
Biochem Pharmacol; 1989 Jul; 38(14):2323-8. PubMed ID: 2473754
[TBL] [Abstract][Full Text] [Related]
4. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole.
Woynarowski JM; McHugh M; Sigmund RD; Beerman TA
Mol Pharmacol; 1989 Feb; 35(2):177-82. PubMed ID: 2465485
[TBL] [Abstract][Full Text] [Related]
5. Distamycin paradoxically stimulates the copying of oligo(dA).poly(dT) by DNA polymerases.
Levy A; Weisman-Shomer P; Fry M
Biochemistry; 1989 Sep; 28(18):7262-7. PubMed ID: 2819066
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of DNA binding to nuclear scaffolds and histone H1 by distamycin. The role of oligo(dA).oligo(dT) tracts.
Käs E; Izaurralde E; Laemmli UK
J Mol Biol; 1989 Dec; 210(3):587-99. PubMed ID: 2614835
[TBL] [Abstract][Full Text] [Related]
7. Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons.
Smith PJ; Bell SM; Dee A; Sykes H
Carcinogenesis; 1990 Apr; 11(4):659-65. PubMed ID: 2157558
[TBL] [Abstract][Full Text] [Related]
8. Effects of two distamycin-ellipticine hybrid molecules on topoisomerase I and II mediated DNA cleavage: relation to cytotoxicity.
Riou JF; Grondard L; Naudin A; Bailly C
Biochem Pharmacol; 1995 Jul; 50(3):424-8. PubMed ID: 7646545
[TBL] [Abstract][Full Text] [Related]
9. Ultraviolet resonance Raman spectroscopy of distamycin complexes with poly(dA)-poly(dT) and poly(dA-dT): role of H-bonding.
Grygon CA; Spiro TG
Biochemistry; 1989 May; 28(10):4397-402. PubMed ID: 2765491
[TBL] [Abstract][Full Text] [Related]
10. DNA structural variations produced by actinomycin and distamycin as revealed by DNAase I footprinting.
Fox KR; Waring MJ
Nucleic Acids Res; 1984 Dec; 12(24):9271-85. PubMed ID: 6393053
[TBL] [Abstract][Full Text] [Related]
11. Distamycin and penta-N-methylpyrrolecarboxamide binding sites on native DNA. A comparison of methidiumpropyl-EDTA-Fe(II) footprinting and DNA affinity cleaving.
Schultz PG; Dervan PB
J Biomol Struct Dyn; 1984 Mar; 1(5):1133-47. PubMed ID: 6101078
[TBL] [Abstract][Full Text] [Related]
12. Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides.
Bell A; Kittler L; Löber G; Zimmer C
Invest New Drugs; 1996; 13(4):271-84. PubMed ID: 8824345
[TBL] [Abstract][Full Text] [Related]
13. DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction.
Bell A; Kittler L; Löber G; Zimmer C
J Mol Recognit; 1997; 10(6):245-55. PubMed ID: 9770648
[TBL] [Abstract][Full Text] [Related]
14. In vitro preferential topoisomerization of bent DNA.
Caserta M; Amadei A; Di Mauro E; Camilloni G
Nucleic Acids Res; 1989 Nov; 17(21):8463-74. PubMed ID: 2555772
[TBL] [Abstract][Full Text] [Related]
15. Binding to DNA of selected lexitropsins and effects on prokaryotic topoisomerase activity.
Burckhardt G; Luck G; Störl K; Zimmer C; Lown JW
Biochim Biophys Acta; 1993 Jun; 1173(3):266-72. PubMed ID: 8391323
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic topoisomerase I-DNA interaction is stabilized by helix curvature.
Krogh S; Mortensen UH; Westergaard O; Bonven BJ
Nucleic Acids Res; 1991 Mar; 19(6):1235-41. PubMed ID: 1851553
[TBL] [Abstract][Full Text] [Related]
17. Detection of drug binding to DNA by hydroxyl radical footprinting. Relationship of distamycin binding sites to DNA structure and positioned nucleosomes on 5S RNA genes of Xenopus.
Churchill ME; Hayes JJ; Tullius TD
Biochemistry; 1990 Jun; 29(25):6043-50. PubMed ID: 1696501
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human DNA topoisomerase I by new DNA minor groove ligands: derivatives of oligo-1,3-thiazolecarboxamides.
Bugreev DV; Vasyutina EL; Ryabinin VA; Sinyakov AN; Buneva VN; Nevinsky GA
Antisense Nucleic Acid Drug Dev; 2001 Jun; 11(3):137-47. PubMed ID: 11446589
[TBL] [Abstract][Full Text] [Related]
19. [Specific protection of DNA by distamycin A, netropsin and bis-netropsins against the action of DNAse I].
Skamrov AV; Rybalkin IN; Bibilashvili RSh; Gottikh BP; Grokhovskiĭ SL
Mol Biol (Mosk); 1985; 19(1):177-95. PubMed ID: 2984546
[TBL] [Abstract][Full Text] [Related]
20. DNA-binding properties of a distamycin-ellipticine hybrid molecule.
Bailly C; O'Huigin C; Houssin R; Colson P; Houssier C; Rivalle C; Bisagni E; Henichart JP; Waring MJ
Mol Pharmacol; 1992 May; 41(5):845-55. PubMed ID: 1588919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
